ESCRS - Pet spiders and the eye

Pet spiders and the eye

Arachnid house pets drive apparent rise in ophthalmia nodosa incidence

Pet spiders and the eye
Howard Larkin
Howard Larkin
Published: Sunday, April 1, 2018
The previously healthy 17-year-old male presented after two weeks of intense foreign body sensation, photophobia and periocular rash that had spontaneously resolved. Though his visual acuity was 20/20, IOP normal and skin on the lids appeared normal, his conjunctiva was diffusely injected, and he had nummular stromal opacities scattered about the cornea, associated with 2+ cell and flare of the anterior chamber. At the slit lamp, discrete corneal lesions were observed. Some were superficial, others very deep, and each lesion was associated with a small, linear refractile structure. One of these structures perforated the posterior cornea and was associated with keratic precipitate on the endothelium, Mark J Mannis MD told the American Academy of Ophthalmology 2017 Annual Meeting in New Orleans, USA. Having seen similar cases, Dr Mannis suspected ophthalmia nodosa. First described by Saemich in 1904, it is caused by setae – fine, sharp spines or hairs – launched by some caterpillars and spiders to discourage potential predators. The spines measure from 0.06mm to 1.5mm, are coated with irritating proteins and have microscopic barbs that prevent them from backing out once they are embedded in tissues. In the eye, rubbing and movement of the globe propel the spines deeper, potentially into the anterior chamber, iris, lens, vitreous or even the retina. So Dr Mannis asked some pointed questions – and the patient revealed he had a pet tarantula. “Interestingly, his name was Blade,” Dr Mannis said. GROWING THREAT Tarantulas are an increasingly common household pet, said Dr Mannis, of the University of California – Davis Eye Center, Sacramento, California, USA. Many varieties, particular non-venomous species as large as 30cm in diameter from Mexico and Brazil, defend themselves by rubbing their legs across their dorsal abdomen, spraying clouds of barbed hairs into the air. As a result, ophthalmia nodosa is increasingly seen. Ophthalmic manifestations include conjunctivitis, localised or diffuse keratitis, iridocyclitis and even chorioretinitis and endophthalmitis. Natural history generally progresses from initial reaction to a quiescent interval, followed by resolution or advancing to iritis and keratoconjunctivitis, with periodic recurrences, Dr Mannis said (Watson PG, Sevel D. BJO 1966; 50:209-217). Treatment consists of observation and topical corticosteroids, Dr Mannis said. Outcomes are variable, ranging from spontaneous resolution leaving behind small corneal scars, to chronic iritis, granuloma formation or even phthisis bulbi. “My advice to the clinician is, take a careful history and know what your patient is exposed to. My advice to the patient is – get a dog,” Dr Mannis concluded. Mark J Mannis: mjmannis@ucdavis.edu
Latest Articles
Simulators Benefit Surgeons and Patients

Helping young surgeons build confidence and expertise.

Read more...

Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...